Next Generation Drug Conjugates market Analysis and Trends by 2023-2035
Driven by the diverse advantages of the next generation drug conjugates, such as non-immunogenic nature, targeted delivery to the site of action, the demand for next generation drug conjugates has increased multifold.
As a result, pharmaceutical companies have started utilizing various synergistic combinations between targeting ligand and payloads to obtain potent next generation drug conjugate for therapeutic efficacy.
The financial opportunity within the next generation drug conjugates market has been analysed across the following segments:
§ Type of Conjugate
§ Peptide-Radionuclide Conjugate
§ Ligand Mediated RNAi Conjugate
§ Ligand Conjugated Anti Sense Medicine
§ Type of Targeting Ligand
§ Amino Sugar
§ Peptide
§ Lipids
§ Type of Payload
§ Radionuclide
§ Drugs
§ Antisense Oligonucleotide
§ si-RNA
§ Type of Therapy
§ Monotherapy
§ Combination Therapy
§ Route of Administration
§ Subcutaneous
§ Intravenous
§ Target Disease Indications
§ Gastroenteropancreatic Neuroendocrine Tumor
§ Prostate Cancer
§ Leptomeningeal Carcinomatosis
§ Hereditary Transthyretin Amyloidosis
§ Atherosclerotic Cardiovascular Disease
§ Severe Hypertriglyceridemia
§ Sleep Disorders
§ Hereditary Angioedema
§ Acute Hepatic Porphyria
§ Primary Hyperoxaluria
§ Heterozygous Familial Hypercholesterolemia
§ Hemophilia
§ Low Risk Myelodysplastic Syndrome
§ Myelofibrosis
§ Alpha-1 Antitrypsin Deficiency Liver Disease
§ Familial Chylomicronemia Syndrome
§ Key Geographical Regions
§ North America
§ Europe
§ Asia-Pacific and Rest of the world
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Company Profiles
6. Clinical Trial Analysis
7. Partnerships and Collaborations
8. Academic Grant Analysis
9. Publication Analysis
10. Drug Failure Analysis
11. Success Protocol Analysis
12. Market Forecast and Opportunity Analysis
13. Appendix I: Tabulated Data
14. Appendix II: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/next-generation-drug-conjugates-market.html
News article
Learn from experts: do you know about these emerging industry trends?
TIL Therapies: Future of Cancer Immunotherapies
Market Landscape of Blockchain Technology used in Drug Discovery and Clinical Trials
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
English